[HTML][HTML] Dendritic cell biology and its role in tumor immunotherapy
…, D Wang, N Li, JT Cheng, YN Lyv, SZ Cui… - Journal of hematology & …, 2020 - Springer
As crucial antigen presenting cells, dendritic cells (DCs) play a vital role in tumor immunotherapy.
Taking into account the many recent advances in DC biology, we discuss how DCs (1) …
Taking into account the many recent advances in DC biology, we discuss how DCs (1) …
A Multifunctional Cascade Bioreactor Based on Hollow‐Structured Cu2MoS4 for Synergetic Cancer Chemo‐Dynamic Therapy/Starvation Therapy/Phototherapy …
…, M Shu, B Ding, C Li, M Pang, S Cui… - Advanced …, 2019 - Wiley Online Library
The unique tumor microenvironment (TME) facilitates cancer proliferation and metastasis,
and it is hard to cure cancer completely via monotherapy. Herein, a multifunctional cascade …
and it is hard to cure cancer completely via monotherapy. Herein, a multifunctional cascade …
[HTML][HTML] The latest battles between EGFR monoclonal antibodies and resistant tumor cells
…, XW Wang, XC Peng, Y Xiang, Z Ma, SZ Cui… - Frontiers in …, 2020 - frontiersin.org
Epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor involved in homeostatic
regulation of normal cells and carcinogenesis of epithelial malignancies. With rapid …
regulation of normal cells and carcinogenesis of epithelial malignancies. With rapid …
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open …
…, Y Bai, Y He, H Zhao, D Zhou, C Dai, G Teng, S Cui… - The Lancet, 2023 - thelancet.com
Background No adjuvant treatment has been established for patients who remain at high
risk for hepatocellular carcinoma recurrence after curative-intent resection or ablation. We …
risk for hepatocellular carcinoma recurrence after curative-intent resection or ablation. We …
[HTML][HTML] Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer
Although Western diet and dysbiosis are the most prominent environmental factors associated
with inflammatory bowel diseases (IBDs), the corresponding host factors and cellular …
with inflammatory bowel diseases (IBDs), the corresponding host factors and cellular …
[HTML][HTML] High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer
J Wang, S Cui, X Zhang, Y Wu, H Tang - PloS one, 2013 - journals.plos.org
<p>The heat shock protein 90 (HSP90) is overexpressed and highly associated with poor
prognosis in many malignancies. However, the role of HSP90 in gastric cancer has not been …
prognosis in many malignancies. However, the role of HSP90 in gastric cancer has not been …
[HTML][HTML] Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies
…, JH Hao, ZG Zhu, DS Wan, LX Qin, SZ Cui… - World journal of …, 2016 - ncbi.nlm.nih.gov
Locoregional spread of abdominopelvic malignant tumors frequently results in peritoneal
carcinomatosis (PC). The prognosis of PC patients treated by conventional systemic …
carcinomatosis (PC). The prognosis of PC patients treated by conventional systemic …
[HTML][HTML] miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway
…, H An, B Wang, Q Liao, W Li, X Jin, S Cui… - European journal of …, 2013 - Elsevier
In recent studies of microRNA expression, miR-133a deregulation was identified in
colorectal carcinoma (CRC). However, the mechanisms underlying the pathogenesis and …
colorectal carcinoma (CRC). However, the mechanisms underlying the pathogenesis and …
[PDF][PDF] An automated organoid platform with inter-organoid homogeneity and inter-patient heterogeneity
…, H Zheng, Z Hu, S Wang, YU Zhu, W Wang, S Cui… - Cell Reports …, 2020 - cell.com
Current organoid technologies require intensive manual manipulation and lack uniformity in
organoid size and cell composition. We present here an automated organoid platform that …
organoid size and cell composition. We present here an automated organoid platform that …
[HTML][HTML] Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Background Gastric cancer (GC) is a common cancer in Asia and currently lacks a targeted
therapy approach. Mesothelin (MSLN) has been reported to be expressed in GC tissue and …
therapy approach. Mesothelin (MSLN) has been reported to be expressed in GC tissue and …